TY - JOUR AU - Chadwick, E. G. AU - Capparelli, E. V. AU - Yogev, R. AU - Pinto, J. A. AU - Robbins, B. AU - Rodman, J. H. AU - Chen, J. AU - Palumbo, P. AU - Serchuck, L. AU - Smith, E. AU - Hughes, M. PY - 2008 DA - 2008// TI - Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results JO - AIDS VL - 22 UR - https://doi.org/10.1097/QAD.0b013e3282f2be1d DO - 10.1097/QAD.0b013e3282f2be1d ID - Chadwick2008 ER - TY - JOUR AU - Ren, Y. AU - Nuttall, J. J. AU - Egbers, C. AU - Eley, B. S. AU - Meyers, T. M. AU - Smith, P. J. AU - Maartens, G. AU - McIlleron, H. M. PY - 2008 DA - 2008// TI - Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis JO - J Acquir Immune Defic Syndr VL - 47 UR - https://doi.org/10.1097/QAI.0b013e3181642257 DO - 10.1097/QAI.0b013e3181642257 ID - Ren2008 ER - TY - JOUR AU - van Zyl, G. U. AU - van der Merwe, L. AU - Claassen, M. AU - Cotton, M. F. AU - Rabie, H. AU - Prozesky, H. W. AU - Preiser, W. PY - 2009 DA - 2009// TI - Protease Inhibitor Resistance in South African Children With Virologic Failure JO - Pediatr Infect Dis J VL - 28 UR - https://doi.org/10.1097/INF.0b013e3181af829d DO - 10.1097/INF.0b013e3181af829d ID - van Zyl2009 ER - TY - JOUR AU - van Zyl, G. U. AU - Claassen, M. AU - Engelbrecht, S. AU - Laten, J. D. AU - Cotton, M. F. AU - Theron, G. B. AU - Preiser, W. PY - 2008 DA - 2008// TI - Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa JO - J Med Virol VL - 80 UR - https://doi.org/10.1002/jmv.21157 DO - 10.1002/jmv.21157 ID - van Zyl2008 ER - TY - JOUR AU - Jaspan, H. B. AU - Berrisford, A. E. AU - Boulle, A. M. PY - 2008 DA - 2008// TI - Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program JO - Pediatr Infect Dis J VL - 27 UR - https://doi.org/10.1097/INF.0b013e31817acf7b DO - 10.1097/INF.0b013e31817acf7b ID - Jaspan2008 ER - TY - JOUR AU - Palumbo, P. AU - Lindsey, J. C. AU - Hughes, M. D. AU - Cotton, M. F. AU - Bobat, R. AU - Meyers, T. AU - Bwakura-Dangarembizi, M. AU - Chi, B. H. AU - Musoke, P. AU - Kamthunzi, P. AU - Schimana, W. AU - Purdue, L. AU - Eshleman, S. H. AU - Abrams, E. J. AU - Millar, L. AU - Petzold, E. AU - Mofenson, L. M. AU - Jean-Philippe, P. AU - Violari, A. PY - 2010 DA - 2010// TI - Antiretroviral treatment for children with peripartum nevirapine exposure JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1000931 DO - 10.1056/NEJMoa1000931 ID - Palumbo2010 ER - TY - BOOK AU - Palumbo, P. AU - Violari, A. AU - Lindsey, J. AU - Hughes, M. AU - Jean-Philippe, P. AU - Mofenson, L. AU - Bwakura-Dangarembizi, M. AU - Kamthunzi, P. AU - Eshleman, S. AU - Purdue, L. PY - 2011 DA - 2011// TI - NVP-vs LPV/r-based ART among HIV+ Infants in Resource-limited Settings: The IMPAACT P1060 Trial 18th Conference on Retroviruses and Oppurtunistic Infections ID - Palumbo2011 ER - TY - STD TI - Coovadia A, Abrams EJ, Stehlau R, Meyers T, Martens L, Sherman G, Hunt G, Hu CC, Tsai WY, Morris L, Kuhn L: Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial.JAMA304(10):1082–1090. ID - ref8 ER - TY - JOUR AU - Frange, P. AU - Briand, N. AU - Avettand-Fenoel, V. AU - Veber, F. AU - Moshous, D. AU - Mahlaoui, N. AU - Rouzioux, C. AU - Blanche, S. AU - Chaix, M. L. PY - 2011 DA - 2011// TI - Lopinavir/Ritonavir-based Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-infected Naive Children: Rare Protease Inhibitor Resistance Mutations But High Lamivudine/Emtricitabine Resistance at the Time of Virologic Failure JO - Pediatr Infect Dis J VL - 30 UR - https://doi.org/10.1097/INF.0b013e31821752d6 DO - 10.1097/INF.0b013e31821752d6 ID - Frange2011 ER - TY - JOUR AU - Soares, E. A. AU - Santos, A. F. AU - Gonzalez, L. M. AU - Lalonde, M. S. AU - Tebit, D. M. AU - Tanuri, A. AU - Arts, E. J. AU - Soares, M. A. PY - 2009 DA - 2009// TI - Mutation T74S in HIV-1 subtype B and C proteases resensitizes them to ritonavir and indinavir and confers fitness advantage JO - J Antimicrob Chemother VL - 64 UR - https://doi.org/10.1093/jac/dkp315 DO - 10.1093/jac/dkp315 ID - Soares2009 ER - TY - JOUR AU - Lwembe, R. AU - Ochieng, W. AU - Panikulam, A. AU - Mongoina, C. O. AU - Palakudy, T. AU - Koizumi, Y. AU - Kageyama, S. AU - Yamamoto, N. AU - Shioda, T. AU - Musoke, R. AU - Owens, M. AU - Songok, E. M. AU - Okoth, F. A. AU - Ichimura, H. PY - 2007 DA - 2007// TI - Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure JO - J Med Virol VL - 79 UR - https://doi.org/10.1002/jmv.20912 DO - 10.1002/jmv.20912 ID - Lwembe2007 ER - TY - JOUR AU - Averbuch, D. AU - Schapiro, J. M. AU - Lanier, E. R. AU - Gradstein, S. AU - Gottesman, G. AU - Kedem, E. AU - Einhorn, M. AU - Grisaru-Soen, G. AU - Ofir, M. AU - Engelhard, D. AU - Grossman, Z. PY - 2006 DA - 2006// TI - Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy JO - Pediatr Infect Dis J VL - 25 UR - https://doi.org/10.1097/01.inf.0000243211.36690.d5 DO - 10.1097/01.inf.0000243211.36690.d5 ID - Averbuch2006 ER - TY - JOUR AU - Barth, R. E. AU - Wensing, A. M. AU - Tempelman, H. A. AU - Moraba, R. AU - Schuurman, R. AU - Hoepelman, A. I. PY - 2008 DA - 2008// TI - Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa JO - AIDS VL - 22 UR - https://doi.org/10.1097/QAD.0b013e328313bf87 DO - 10.1097/QAD.0b013e328313bf87 ID - Barth2008 ER - TY - JOUR AU - Gody, J. C. AU - Charpentier, C. AU - Mbitikon, O. AU - Si-Mohamed, A. AU - LeGoff, J. AU - Gresenguet, G. AU - Belec, L. PY - 2008 DA - 2008// TI - High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations JO - J Acquir Immune Defic Syndr VL - 49 UR - https://doi.org/10.1097/QAI.0b013e318183acae DO - 10.1097/QAI.0b013e318183acae ID - Gody2008 ER - TY - JOUR AU - Germanaud, D. AU - Derache, A. AU - Traore, M. AU - Madec, Y. AU - Toure, S. AU - Dicko, F. AU - Coulibaly, H. AU - Sylla, M. AU - Calvez, V. AU - Marcelin, A. G. PY - 2010 DA - 2010// TI - Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali JO - J Antimicrob Chemother VL - 65 UR - https://doi.org/10.1093/jac/dkp412 DO - 10.1093/jac/dkp412 ID - Germanaud2010 ER - TY - JOUR AU - Paredes, R. AU - Sagar, M. AU - Marconi, V. C. AU - Hoh, R. AU - Martin, J. N. AU - Parkin, N. T. AU - Petropoulos, C. J. AU - Deeks, S. G. AU - Kuritzkes, D. R. PY - 2009 DA - 2009// TI - In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine JO - J Virol VL - 83 UR - https://doi.org/10.1128/JVI.02154-08 DO - 10.1128/JVI.02154-08 ID - Paredes2009 ER - TY - JOUR AU - Turner, D. AU - Brenner, B. G. AU - Routy, J. P. AU - Petrella, M. AU - Wainberg, M. A. PY - 2004 DA - 2004// TI - Rationale for maintenance of the M184v resistance mutation in human immunodeficiency virus type 1 reverse transcriptase in treatment experienced patients JO - New Microbiol VL - 27 ID - Turner2004 ER - TY - JOUR AU - Castagna, A. AU - Danise, A. AU - Menzo, S. AU - Galli, L. AU - Gianotti, N. AU - Carini, E. AU - Boeri, E. AU - Galli, A. AU - Cernuschi, M. AU - Hasson, H. AU - Clementi, M. AU - Lazzarin, A. PY - 2006 DA - 2006// TI - Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study) JO - AIDS VL - 20 UR - https://doi.org/10.1097/01.aids.0000218542.08845.b2 DO - 10.1097/01.aids.0000218542.08845.b2 ID - Castagna2006 ER - TY - JOUR AU - Rakhmanina, N. AU - van den Anker, J. AU - Baghdassarian, A. AU - Soldin, S. AU - Williams, K. AU - Neely, M. N. PY - 2009 DA - 2009// TI - Population pharmacokinetics of lopinavir predict suboptimal therapeutic concentrations in treatment-experienced human immunodeficiency virus-infected children JO - Antimicrob Agents Chemother VL - 53 UR - https://doi.org/10.1128/AAC.01374-08 DO - 10.1128/AAC.01374-08 ID - Rakhmanina2009 ER - TY - BOOK AU - Davies, M. A. AU - Wood, R. AU - van Cutsem, G. AU - Giddy, J. AU - Eley, B. AU - Rabie, H. AU - Moultrie, H. AU - Technau, K. AU - Boulle, A. PY - 2009 DA - 2009// TI - Virologic failure and second-line antiretroviral therapy (ART) in children in South Africa: the international databases to evaluate AIDS (IeDEA) Southern Africa collaboration 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention PB - Cape Town CY - South Africa ID - Davies2009 ER - TY - JOUR AU - van Zyl, G. U. AU - van Mens, T. E. AU - McIlleron, H. AU - Zeier, M. AU - Nachega, J. B. AU - Decloedt, E. AU - Malavazzi, C. AU - Smith, P. AU - Huang, Y. AU - van der Merwe, L. AU - Gandhi, M. AU - Maartens, G. PY - 2011 DA - 2011// TI - Low lopinavir plasma or hair concentrations explain second line protease inhibitor failures in a resource-limited setting JO - J Acquir Immune Defic Syndr VL - 56 UR - https://doi.org/10.1097/QAI.0b013e31820dc0cc DO - 10.1097/QAI.0b013e31820dc0cc ID - van Zyl2011 ER - TY - JOUR AU - Romanelli, F. AU - Empey, K. AU - Pomeroy, C. PY - 2002 DA - 2002// TI - Macrocytosis as an indicator of medication (zidovudine) adherence in patients with HIV infection JO - AIDS Patient Care STDS VL - 16 UR - https://doi.org/10.1089/108729102760330245 DO - 10.1089/108729102760330245 ID - Romanelli2002 ER - TY - JOUR AU - Eyer-Silva, W. A. AU - Arabe, J. AU - Pinto, J. F. AU - Morais-De-Sa, C. A. PY - 2001 DA - 2001// TI - Macrocytosis in patients on stavudine JO - Scand J Infect Dis VL - 33 UR - https://doi.org/10.1080/00365540151061067 DO - 10.1080/00365540151061067 ID - Eyer-Silva2001 ER - TY - JOUR AU - Deeks, S. G. AU - Wrin, T. AU - Liegler, T. AU - Hoh, R. AU - Hayden, M. AU - Barbour, J. D. AU - Hellmann, N. S. AU - Petropoulos, C. J. AU - McCune, J. M. AU - Hellerstein, M. K. AU - Grant, R. M. PY - 2001 DA - 2001// TI - Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200102153440702 DO - 10.1056/NEJM200102153440702 ID - Deeks2001 ER - TY - BOOK AU - Wiznia, A. AU - Samson, P. AU - Acosta, E. PY - 2009 DA - 2009// TI - Safety and efficacy of raltegravir inpediatric HIV infection: preliminary analysis from the international maternal pediatric adolescent AIDS clinical trial group 16th Conference on Retroviruses and Opportunistic Infections PB - Montreal CY - Canada ID - Wiznia2009 ER - TY - JOUR AU - Calmy, A. L. AU - Ford, N. PY - 2011 DA - 2011// TI - Improving treatment outcome for children with HIV JO - Lancet VL - 377 UR - https://doi.org/10.1016/S0140-6736(11)60363-2 DO - 10.1016/S0140-6736(11)60363-2 ID - Calmy2011 ER - TY - JOUR AU - Rodriguez, C. A. AU - Koch, S. AU - Goodenow, M. AU - Sleasman, J. W. PY - 2008 DA - 2008// TI - Clinical implications of discordant viral and immune outcomes following protease inhibitor containing antiretroviral therapy for HIV-infected children JO - Immunol Res VL - 40 UR - https://doi.org/10.1007/s12026-007-0031-1 DO - 10.1007/s12026-007-0031-1 ID - Rodriguez2008 ER -